Fujirebio Europe N.V.
6 FDA 510(k) clearances · PMA applicant
| Record | Firm | Date |
|---|---|---|
| VERSANT HCV Genotype 2.0 Assay (LiPA) (P160016/S005) | Fujirebio Europe N.V. | 2020-09-23 |
| VERSANT HCV Genotype 2.0 Assay (LiPA) (P160016/S006) | Fujirebio Europe N.V. | 2020-08-27 |
| Versant HCV Genotype 2.0 Assay (LiPA) (P160016/S004) | Fujirebio Europe N.V. | 2019-09-20 |
| VERSANT HCV Genotype 2.0 Assay (LiPA) (P160016/S003) | Fujirebio Europe N.V. | 2019-04-05 |
| VERSANT HCV Genotype 2.0 Assay (LiPA) (P160016/S001) | Fujirebio Europe N.V. | 2018-02-08 |
| VERSANT HCV GENOTYPE 2.0 ASSAY (LiPA) (P160016) | Fujirebio Europe N.V. | 2017-03-14 |
Track Fujirebio Europe N.V. automatically
Every clearance here is in the API, with alerts when new ones post.